Skip to main content
. 2026 Jul 3;26:257. doi: 10.1186/s12873-026-01675-9

Table 1.

Demographic and clinical characteristics of the patients

Variables Diagnosis
Peripheral Central p-value
Total- n (%) 236 (79.2) 62 (20.8) -
Demographics and vital signs Age (year)- mean ± SD 50.28 ± 16.31 57.97 ± 14.23 < 0.001*
Gender- n (%) Male 88 (68.21) 41 (31.79) < 0.001‡
Female 148 (87.57) 21 (12.43)
Diabetes Mellitus- n (%) 36 (70.58) 15 (29.22) 0.096‡
Hypertension- n (%) 57 (70.37) 24 (29.63) 0.022‡
Chronic Obstructive Pulmonary Disease- n (%) 3 (60) 2 (40) 0.279§
Cerebrovascular Disease- n (%) 5 (41.66) 7 (58.34) 0.004§
Chronic Kidney Failure- n (%) 0 (0) 1 (100) 0.208§
Chronic Heart Failure- n (%) 2 (66.66) 1 (33.34) 0.505§
Malignancy 2 (66.66) 1 (33.34) 0.505§
Systolic Blood Pressure (mmHg)- mean ± SD 135.69 ± 20.72 146.52 ± 22.71 0.001*
Diastolic Blood Pressure (mmHg)- mean ± SD 76.92 ± 13.47 81.84 ± 15.04 0.001*
Heart Rate (/min)- med (25–75%) 86 (78–95) 88 (78–95) 0.663†
SpO2 (%) 99 (97–99) 99 (96–99) 0.905†
Symptoms Lightheadedness- n (%) 123(70.28) 52(29.72) < 0.001‡
Nausea- n (%) 107 (76.97) 32 (23.03) 0.378‡
Vomiting- n (%) 107 (76.97) 32 (23.03) 0.378‡
Headache- n (%) 43 (75.43) 14 (24.57) 0.437‡
HINTS-Plus components Head impulse- n (%) Peripheral 206 (91.96) 18 (8.04) < 0.001‡
Central 30 (40.54) 44 (59.46)
Nystagmus- n (%)** Peripheral 230 (85.5) 39 (14.5) < 0.001‡
Central 6 (20.68) 23 (70.32)
Test of skew- n (%) Peripheral 219 (84.88) 39 (15.12) < 0.001‡
Central 17 (42.5) 23 (57.5)
Hearing loss- n (%) Peripheral 231 (79.65) 59 (20.35) 0.370§
Central 5 (62.5) 3 (37.5)
HINTS Plus test Peripheral 195 (94.2) 12 (5.8) < 0.001‡
Central 41 (45.05) 50 (54.95)
HINTS test Peripheral 198 (93.83) 13 (6.17) < 0.001‡
Central 38 (43.67) 49 (56.33)

* Student T test

‡ Pearson Chi-Square test

§ Fisher’s Exact test

† Mann Whitney U test

**Peripheral: Horizontal nystagmus. Central: Vertical or rotatory nystagmus